153 related articles for article (PubMed ID: 24201744)
1. Long-term outcomes and prognostic factors with reductive hepatectomy and sequential percutaneous isolated hepatic perfusion for multiple bilobar hepatocellular carcinoma.
Fukumoto T; Tominaga M; Kido M; Takebe A; Tanaka M; Kuramitsu K; Matsumoto I; Ajiki T; Ku Y
Ann Surg Oncol; 2014 Mar; 21(3):971-8. PubMed ID: 24201744
[TBL] [Abstract][Full Text] [Related]
2. Reductive surgery plus percutaneous isolated hepatic perfusion for multiple advanced hepatocellular carcinoma.
Ku Y; Iwasaki T; Tominaga M; Fukumoto T; Takahashi T; Kido M; Ogata S; Takahashi M; Kuroda Y; Matsumoto S; Obara H
Ann Surg; 2004 Jan; 239(1):53-60. PubMed ID: 14685100
[TBL] [Abstract][Full Text] [Related]
3. [Sustained complete remission with reductive surgery plus percutaneous isolated hepatic perfusion (PIHP) for bilobar multiple hepatocellular carcinoma with portal venous tumor thrombus--a case report].
Tanaka M; Tominaga M; Iwasaki T; Fukumoto T; Kusunoki N; Sugimoto T; Tsuchida S; Kido M; Takebe A; Kinoshita H; Ku Y
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1815-7. PubMed ID: 16315950
[TBL] [Abstract][Full Text] [Related]
4. [A case of Vp4 portal vein tumor thrombosis--a complete remission achieved with dual treatment of surgery plus percutaneous isolated hepatic perfusion].
Chuma M; Fukumoto T; Kusunoki N; Tsuchida S; Kido M; Takahashi M; Tsugawa D; Awazu M; Kataoka Y; Matsumoto I; Hori Y; Kuroda D; Ku Y
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2300-2. PubMed ID: 21224554
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the safety and efficacy of percutaneous isolated hepatic perfusion after particle therapy for advanced hepatocellular carcinoma].
Tanaka M; Fukumoto T; Kido M; Takebe A; Kuramitsu K; Kinoshita H; Komatsu S; Fukushima K; Urade T; So S; Shinzeki M; Matsumoto I; Ajiki T; Terashima K; Fujii O; Demizu Y; Fuwa N; Ku Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1681-3. PubMed ID: 24393887
[TBL] [Abstract][Full Text] [Related]
6. [A long-term survival case of postoperative lymph node metastases from hepatocellular carcinoma treated with lymph node dissection and percutaneous isolated hepatic perfusion (PIHP)].
Tsugawa D; Fukumoto T; Kusunoki N; Tsuchida S; Sendo H; Kido M; Takahashi M; Takebe A; Awazu M; Kataoka Y; Matsumoto I; Ajiki T; Hori Y; Suzuki S; Kuroda D; Ku Y
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2312-4. PubMed ID: 21224557
[TBL] [Abstract][Full Text] [Related]
7. [The role of preoperative percutaneous isolated hepatic perfusion and hepatectomy in multidisciplinary treatment].
Yoshida T; Kido M; Fukumoto T; Komatsu S; Takahashi M; Takebe A; Tanaka M; Kuramitsu K; Kinoshita H; Ajiki T; Matsumoto I; Shinzeki M; Okazaki T; Asari S; Ku Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1822-4. PubMed ID: 24393934
[TBL] [Abstract][Full Text] [Related]
8. [Phase I study of super high-dose chemotherapy for liver cancer with percutaneous isolated hepatic perfusion (PIHP) and peripheral blood stem cell transplantation (PBSCT)].
Takahashi T; Ku Y; Tominaga M; Iwasaki T; Fukumoto T; Takamatsu M; Tsuchida S; Sendou H; Suzuki Y; Kuroda Y
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1801-4. PubMed ID: 11086416
[TBL] [Abstract][Full Text] [Related]
9. [A case of multiple hepatocellular carcinoma with rapidly progressing bilateral portal vein tumor thrombosis--a complete remission achieved with dual treatment of reductive surgery plus percutaneous isolated hepatic perfusion].
Tsuchida S; Fukumoto T; Tominaga M; Iwasaki T; Kusunoki N; Sugimoto T; Kido M; Takebe A; Tanaka M; Hisoka K; Ku Y
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1818-20. PubMed ID: 16315951
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection after down-staging of locally advanced hepatocellular carcinoma by localized concurrent chemoradiotherapy.
Lee HS; Choi GH; Choi JS; Kim KS; Han KH; Seong J; Ahn SH; Kim DY; Park JY; Kim SU; Kim BK
Ann Surg Oncol; 2014 Oct; 21(11):3646-53. PubMed ID: 24916746
[TBL] [Abstract][Full Text] [Related]
11. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155
[TBL] [Abstract][Full Text] [Related]
12. [The long-term results of percutaneous isolated hepatic perfusion for patients with advanced hepatocellular carcinoma].
Ku Y; Tominaga M; Iwasaki T; Fukumoto T; Muramatsu S; Kusunoki N; Kuroda Y; Matsumoto S; Hirota S
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1266-8. PubMed ID: 9703804
[TBL] [Abstract][Full Text] [Related]
13. [A case of bilobar multiple hepatocellular carcinoma in which complete remission was achieved by preoperative percutaneous isolated hepatic perfusion and subsequent hepatectomy].
Urade T; Tanaka M; Fukumoto T; Kido M; Tsuchida S; Takahashi M; Takebe A; Kuramitsu K; Awazu M; Chuma M; Fukushima K; So S; Tai K; Fujimoto M; Toyama H; Shinzeki M; Matsumoto I; Ajiki T; Ku Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1825-7. PubMed ID: 23267899
[TBL] [Abstract][Full Text] [Related]
14. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I
Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous ablative therapies of recurrent hepatocellular carcinoma after hepatectomy: proposal of a prognostic model.
Yin XY; Xie XY; Lu MD; Kuang M; Liu GJ; Xu ZF; Xu HX; Wang Z
Ann Surg Oncol; 2012 Dec; 19(13):4300-6. PubMed ID: 22766980
[TBL] [Abstract][Full Text] [Related]
16. Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases.
Jung SM; Jang JW; You CR; Yoo SH; Kwon JH; Bae SH; Choi JY; Yoon SK; Chung KW; Kay CS; Jung HS
J Gastroenterol Hepatol; 2012 Apr; 27(4):684-9. PubMed ID: 21916984
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.
Xu HX; Lu MD; Xie XY; Yin XY; Kuang M; Chen JW; Xu ZF; Liu GJ
Clin Radiol; 2005 Sep; 60(9):1018-25. PubMed ID: 16124984
[TBL] [Abstract][Full Text] [Related]
18. [A case of multiple hepatocellular carcinoma complicated with N3 regional lymph node metastases preventing tumor progression by gradual introduction of lymph node excision and high-dose chemotherapy using percutaneous isolated hepatic perfusion].
Samizo M; Ku Y; Kuroda Y
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1900-2. PubMed ID: 10560421
[TBL] [Abstract][Full Text] [Related]
19. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of operative and non-operative treatment in hepatocellular carcinoma with main portal vein tumor thrombus].
Tanaka Y; Otani Y; Tsukui M; Goto K; Makuuchi H; Tajima T; Mitomi T
Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1111-4. PubMed ID: 1335117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
